| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2018 | 2016 | 2015 | 2014 | 2013 | 2012 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 12,4 k € | -69.0% | 40,2 k € | +3.1% | 38,9 k € | -6.2% | 41,5 k € | -17.6% | 50,4 k € | -17.0% | 60,7 k € | +3.1% | 58,9 k € | +31.4% | 44,8 k € | -73.9% | 172,0 k € | +33.7% | 128,6 k € | +143.4% | 52,8 k € | -9.2% | 58,2 k € | +598.4% | 8,3 k € | +490.9% | -2,1 k € | |
| EBITDA | 11,9 k € | -70.0% | 39,6 k € | +3.2% | 38,4 k € | -6.4% | 41,1 k € | -17.7% | 49,9 k € | -17.2% | 60,2 k € | +3.4% | 58,2 k € | +53.7% | 37,9 k € | -44.6% | 68,4 k € | -41.1% | 116,2 k € | +126.4% | 51,3 k € | -9.2% | 56,5 k € | +890.9% | 5,7 k € | +181.5% | -7,0 k € | |
| Operating profit | 11,9 k € | +21.8% | 9,8 k € | +271.4% | 2,6 k € | -51.7% | 5,5 k € | -61.9% | 14,3 k € | -41.9% | 24,6 k € | +8.8% | 22,6 k € | +175.4% | 8,2 k € | +117.2% | -47,7 k € | -190.9% | 52,6 k € | +580.0% | 7,7 k € | -81.9% | 42,7 k € | +638.0% | -7,9 k € | +84.1% | -49,9 k € | |
| Profit/loss | 9,1 k € | +23.8% | 7,3 k € | +358.0% | 1,6 k € | -57.0% | 3,7 k € | -69.1% | 12,1 k € | -47.3% | 22,9 k € | +7.8% | 21,2 k € | +476.7% | 3,7 k € | +106.2% | -59,3 k € | -286.3% | 31,8 k € | +4779.4% | 652,5 € | -98.5% | 42,4 k € | +631.4% | -8,0 k € | +84.0% | -49,9 k € | |
| Equity | 35,8 k € | +34.1% | 26,7 k € | +38.0% | 19,3 k € | +9.0% | 17,7 k € | +26.6% | 14,0 k € | +626.5% | 1,9 k € | +109.2% | -21,0 k € | +50.3% | -42,2 k € | +8.0% | -45,9 k € | -442.2% | 13,4 k € | +652.0% | -2,4 k € | +21.2% | -3,1 k € | +93.2% | -45,5 k € | -21.3% | -37,5 k € | |
| Total assets | 40,0 k € | +27.8% | 31,3 k € | -43.9% | 55,8 k € | -36.6% | 88,0 k € | -29.6% | 125,0 k € | -18.0% | 152,5 k € | -14.2% | 177,8 k € | -35.0% | 273,5 k € | -22.2% | 351,4 k € | -51.7% | 727,7 k € | -3.0% | 750,6 k € | +262.5% | 207,0 k € | +14.6% | 180,6 k € | -5.8% | 191,8 k € | |
| Cash | 1,0 k € | -73.6% | 3,9 k € | -69.6% | 12,9 k € | +13.9% | 11,3 k € | -2.3% | 11,6 k € | +6.6% | 10,9 k € | +2128.1% | 488,3 € | -93.1% | 7,1 k € | +114.3% | 3,3 k € | -92.7% | 45,0 k € | -50.6% | 91,3 k € | +101.6% | 45,3 k € | +402.0% | 9,0 k € | +146.6% | 3,7 k € | |
| Debts | 4,2 k € | -8.6% | 4,6 k € | -87.4% | 36,4 k € | -48.1% | 70,2 k € | -36.7% | 111,0 k € | -25.4% | 148,9 k € | -24.1% | 196,3 k € | -37.6% | 314,4 k € | -20.9% | 397,3 k € | -43.5% | 703,6 k € | -6.5% | 752,3 k € | +259.3% | 209,4 k € | -7.4% | 226,1 k € | -1.4% | 229,3 k € | |
| Staff | — | — | — | — | — | — | — | — | 0,2 | — | — | — | — | — | ||||||||||||||
Private limited company · Gent · incorporated on 17/12/2010
Private limited company profitable and well capitalised. Cash position declining (-73.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
FARMALINE is a Private limited company incorporated in 2010. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette